BIO supports the EUs objectives of increasing access to medicines and fostering innovation. We welcome the EUs efforts to enhance the regulatory environment, including the use of expedited pathways, streamlining regulatory decision-making processes, and reducing administrative burdens.
BIO
Biotechnology Innovation Organization
Industry association · United States
not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.
2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
1
with a full position paper
attached to a submission
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Track Biotechnology in PolicySpeak: request access →
Work at Biotechnology Innovation Organization? so we know who speaks for it.
Their record over time
Biotechnology Innovation Organization filed 2 positions between 30 Jul 2023 and 8 Nov 2023, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.
What they argued
BIO is deeply concerned with the Commissions initiative to revise its compulsory licensing (CL) legislation. The proposal of a revised CL regime suggests that the envisioned new framework remedies a dysfunctional system despite no objective evidence that the existing regime is inadequate.
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Biotechnology Innovation Organization next to another organization. Same files, same register facts, side by side. Compare →
Turns up on the same files
Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.
Showing 5 of 23.
Is this your organization?
Everything on this page comes from Biotechnology Innovation Organization’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.